Hong Kong Researchers Achieve Longer Mesothelioma Lifespan With Enzyme Inhibitor

Researchers from the University of Hong Kong have just revealed that by using an enzyme inhibitor called DFMO on mice infected with malignant pleural mesothelioma, they were able to extend the animals’ lifespan.

Inhibiting enzyme stops the production of polyamine

Writing in the Journal of Clinical Oncology, the study’s authors indicated that DFMO seems to stop the production of polyamines in mesothelioma cells. Polyamines are found in all cells, and have been cited as one possible reason why the rare asbestos-related cancer is able to grow and spread so quickly, as mesothelioma tumors produce an enzyme that accelerates polyamine levels.  The researchers found that after DFMO was administered, the cancerous cells stopped proliferating, and believe it is because the substance stops the enzyme’s action.

The researchers conducted two different experiments to determine DMFO’s impact on mesothelioma: in the first they gave the substance to mice, in water, for a week prior to injecting them with mesothelioma cells. In the second they injected the animals with mesothelioma first, then gave them the DFMO in water after the cells had grown to a specific size.

Two different applications of DMFO yield positive results

In analyzing the mesothelioma tumors in the animals, the researchers found that DMFO provided longer median survival rates for both groups, with 43% of the mice considered long-term survivors. DMFO was first developed nearly 50 years ago, and is not without its risks. It has been determined to cause hearing loss when given at high levels, though at lower dosages it has been shown to be safe. Though initial studies of its impact on cancer were disappointing, more recent research has revealed that it is most effective when used in cancers that are a result of exposure to carcinogenic material. Malignant mesothelioma is caused by exposure to asbestos.

With each new discovery by cancer researchers, mesothelioma victims have a bit more hope that a cure will be found. If you need information on any of the available treatments or resources available to you, contact the Patient Advocates at Mesothelioma.net today at 1-800-692-8608.

Terri Heimann Oppenheimer

Terri Oppenheimer

Terri Heimann Oppenheimer is the head writer of our Mesothelioma.net news blog. She graduated from the College of William and Mary with a degree in English. Terri believes that knowledge is power and she is committed to sharing news about the impact of mesothelioma, the latest research and medical breakthroughs, and victims’ stories.

Learn More About And Contact Terri
Get Help Contacting Mesothelioma.net
This field is for validation purposes and should be left unchanged.
24/7 Live Chat
Online Now